Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lamivudine/tenofovir disoproxil fumarate - Celltrion

Next Previous
Drug Profile

Lamivudine/tenofovir disoproxil fumarate - Celltrion

Alternative Names: TEMIXYS; Tenofovir disoproxil fumarate/lamivudine - Celltrion

Latest Information Update: 07 Oct 2019

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Celltrion
  • Class Antiretrovirals; Deoxyribonucleosides; Dideoxynucleosides; Phosphonic acids; Purines; Pyrimidine nucleosides; Small molecules
  • Mechanism of Action Nucleoside reverse transcriptase inhibitors; Nucleotide reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered HIV-1 infections

Most Recent Events

  • 30 Sep 2019 Celltrion plans to launch lamivudine/tenofovir disoproxil fumarate for HIV-1 infections in USA in 2019
  • 04 Jan 2019 Chemical structure information added
  • 16 Nov 2018 Registered for HIV-1 infections (Combination therapy, In children, In adolescents, In adults) in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top